First Horizon Corporation’s Medifast MED Stock Holding History

First Horizon Corporation’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$3K	Hold	12	–	–	﹤0.01%	909
2021 Q1	$2K	Hold	12	–	–	﹤0.01%	931
2020 Q4	$2K	Hold	12	–	–	﹤0.01%	917
2020 Q3	$1K	Buy	+12	New	+$1.98K	﹤0.01%	955

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First Horizon Corporation's MED Position: Q2 2021 in Review

First Horizon Corporation held its Medifast (MED) position steady in Q2 2021 at 12 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #909.

First Horizon Corporation first reported a position in MED in Q3 2020 and has held it in 4 quarters since. 301 funds tracked by Wall St. Rank hold MED as of Q2 2021.

First Horizon Corporation held 12 shares of Medifast worth $3K as of Q2 2021.
First Horizon Corporation left its Medifast share count unchanged in Q2 2021.
Medifast made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2021, its #909 holding.
First Horizon Corporation first reported a position in Medifast in Q3 2020 and has held it in 4 quarters since.
301 funds tracked by Wall St. Rank held Medifast as of Q2 2021.

Based on First Horizon Corporation's 13F filing for Q2 2021, filed 9 Aug 2021.